Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications

New agreement supersedes the collaboration agreement entered in 2012GSK retains non-exclusive right to use PRINT for pre-clinical research for inhaled deliveryLiquidia can apply PRINT to any... | April 3, 2023

Related Keywords

,Roger Jeffs ,Jason Adair ,Liquidia Technologies Inc ,Corporate Development ,York Heart Association ,United Therapeutics Corporation ,Liquidia Corporation ,Drug Administration ,Chief Executive Officer ,New York Heart Association ,Functional Class ,Dry Powder Inhalation ,United Therapeutics ,Liquidia Technologies ,Private Securities Litigation Reform Act ,Vice President ,Liquidia Corporation Stock Exchange ,News ,Information ,Press Release ,Few ,Agreement ,Supersedes ,The ,Collaboration ,Ntered ,N ,012gsk ,Etains ,Flight ,O ,Tse ,Sprint ,Or ,Research ,Inhaled ,Eliveryliquidia ,Han ,Apply ,O Lqda Us53635d2027 ,